371 related articles for article (PubMed ID: 31629252)
1. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells.
Tan Q; Lin S; Zeng Y; Yao M; Liu K; Yuan H; Liu C; Jiang G
Environ Toxicol; 2020 Jun; 35(6):643-651. PubMed ID: 31916386
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
6. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells.
Zhang YH; Li HD; Li B; Jiang SD; Jiang LS
Oncol Rep; 2014 Feb; 31(2):919-25. PubMed ID: 24337872
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune.
Jiang Z; Yang Y; Yang Y; Zhang Y; Yue Z; Pan Z; Ren X
Biomed Pharmacother; 2017 Dec; 96():378-383. PubMed ID: 29031195
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
Zou J; Su H; Zou C; Liang X; Fei Z
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
[TBL] [Abstract][Full Text] [Related]
10. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
Jian J; Hu ZF; Huang Y
Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway.
Li J; Yang B
In Vitro Cell Dev Biol Anim; 2023 Jan; 59(1):19-30. PubMed ID: 36790693
[TBL] [Abstract][Full Text] [Related]
13. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
Yu X; Wang Q; Dai Z
J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
[TBL] [Abstract][Full Text] [Related]
14. 20(
Liang Y; Zhang T; Jing S; Zuo P; Li T; Wang Y; Xing S; Zhang J; Wei Z
Am J Chin Med; 2021; 49(3):753-765. PubMed ID: 33641655
[TBL] [Abstract][Full Text] [Related]
15. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells.
Zhao L; Shou H; Chen L; Gao W; Fang C; Zhang P
Oncol Rep; 2019 Jun; 41(6):3209-3218. PubMed ID: 31002353
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats.
Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y
J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612
[TBL] [Abstract][Full Text] [Related]
17. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
Lu M; Fei Z; Zhang G
Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein.
Luo Y; Zhang P; Zeng HQ; Lou SF; Wang DX
Mol Med Rep; 2015 Sep; 12(3):3557-3562. PubMed ID: 25998024
[TBL] [Abstract][Full Text] [Related]
20. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]